InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: reachjo post# 454551

Monday, 03/28/2022 11:18:36 PM

Monday, March 28, 2022 11:18:36 PM

Post# of 693026
I am with Gary on this one. The value of companies are valued in market cap not stock price. $100 per share is reachable with 5 for 1 reverse split and immediate surprise up list. It has been done before in a different and resulted in 350% price rise in a few weeks. ( Anavex October 2015 surprise up list to NASDAQ from OTC- a reverse split and up list same day) Then the burned short sellers took revenge for four years. But that same company ballooned 25x four years later in 18 months from Dec 2018 from $1.26 to $30 in a spike of a few weeks mostly on price explosions on no news. So yes can reach $100 post split ..$20 split adjusted but need an up list. I favor NYSE-Amex and a listing on London Stock Exchange. Better yet re- domicile in Ireland with primary listing in London and secuondary on AMEX. Look at the history of other Biotechs that had their growth phases in the last 20 years. GILD had a greatly expanded market cap but it was not from the organic approval of Viread but after the acquisition of Pharmasett and the market cap grew spectacularly yet slowly but surely.
I appreciate your enthusiasm. Stranger things than what you postulated have happened. NWBO could spike as high as $100 could spike as high as $100 but likely would retrace to $20-45. Anavex trades on the $12 handle now and the $30 spike did not even hold for two days.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News